| 000 | 01793 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513045235.0 | ||
| 264 | 0 | _c19950309 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/bjc.1995.72 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThomas, H | |
| 245 | 0 | 0 |
_aProliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer? _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cFeb 1995 |
||
| 300 |
_a357-62 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xanalysis |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aCarboplatin _xtherapeutic use |
| 650 | 0 | 4 | _aCell Division |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aEngland _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aLaparotomy |
| 650 | 0 | 4 | _aLife Tables |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xchemistry |
| 650 | 0 | 4 | _aParaffin Embedding |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xanalysis |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aNasim, M M | |
| 700 | 1 | _aSarraf, C E | |
| 700 | 1 | _aAlison, M R | |
| 700 | 1 | _aLove, S | |
| 700 | 1 | _aLambert, H E | |
| 700 | 1 | _aPrice, P | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 71 _gno. 2 _gp. 357-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.1995.72 _zAvailable from publisher's website |
| 999 |
_c7840392 _d7840392 |
||